{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:41:08Z","timestamp":1790286068790,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Australian National Health and Medical Research Council for a Centre of Research Excellence","award":["APP1099452"],"award-info":[{"award-number":["APP1099452"]}]},{"name":"Australian National Health and Medical Research Council for a Centre of Research Excellence","award":["APP1044941"],"award-info":[{"award-number":["APP1044941"]}]},{"name":"Intensive Care Foundation. Jason Roberts","award":["APP1117065"],"award-info":[{"award-number":["APP1117065"]}]},{"name":"National Health and Medical Research Council of Australia"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ijantimicag.2018.03.001","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T21:14:45Z","timestamp":1520543685000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy"],"prefix":"10.1016","volume":"52","author":[{"given":"Caleb J P","family":"Economou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan T.","family":"Kielstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Czock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Tallott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3103-0048","authenticated-orcid":false,"given":"Carsten","family":"Hafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius J","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6218-435X","authenticated-orcid":false,"given":"Jason A","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrneph.2011.13","article-title":"Acute kidney injury: what's the prognosis?","volume":"7","author":"Murugan","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0002","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2010050484","article-title":"Sepsis and acute kidney injury","volume":"22","author":"Zarjou","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0003","article-title":"The distant organ effects of acute kidney injury","author":"Grams","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0004","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","article-title":"Intensity of continuous renal-replacement therapy in critically ill patients","volume":"361","author":"Bellomo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0005","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1097\/CCM.0b013e318246bd85","article-title":"Measurement of renal blood flow by phase-contrast magnetic resonance imaging during septic acute kidney injury: A pilot investigation","volume":"60","author":"Prowle","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0006","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1053\/j.ajkd.2003.10.021","article-title":"Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study","volume":"43","author":"Kielstein","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0007","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ki.2009.541","article-title":"Hemodiafiltration: clinical evidence and remaining questions","volume":"77","author":"Blankestijn","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0008","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000000317","article-title":"The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens","author":"Jamal","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.CCM.0000190243.88133.3F","article-title":"Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis","volume":"34","author":"Kielstein","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0011","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0012","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","article-title":"Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R","volume":"34","author":"Neely","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0013","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10928-013-9302-8","article-title":"Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian","volume":"40","author":"Tatarinova","year":"2013","journal-title":"Journal of pharmacokinetics and pharmacodynamics"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0014","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10928-005-0016-4","article-title":"Prediction discrepancies for the evaluation of nonlinear mixed-effects models","volume":"33","author":"Mentre","year":"2006","journal-title":"Journal of pharmacokinetics and pharmacodynamics"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0016","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000343162","article-title":"Is peak concentrations needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic- pharmacodynamic analysis in patients with methicillin-resistant Staphylococcus aureus pneumonia","volume":"58","author":"Suzuki","year":"2012","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0017","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01694710","article-title":"Pharmacokinetics of vancomycin during continuous hemodiafiltration","volume":"19","author":"Santre","year":"1993","journal-title":"Intensive care medicine"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0018","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2125.2004.02143.x","article-title":"Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration","volume":"58","author":"DelDot","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0019","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijantimicag.2014.03.009","article-title":"Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration","volume":"44","author":"Escobar","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0020","doi-asserted-by":"crossref","unstructured":"Udy AA, Covajes C, Taccone FS, Jacobs F, Vincent JL, Lipman J, et al. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients? Int J Antimicrob Agents. 2013;41:564-8.","DOI":"10.1016\/j.ijantimicag.2013.01.018"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0021","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5507\/bp.2012.002","article-title":"Vancomycin removal during low-flux and high-flux extended daily hemodialysis in critically ill septic patients","volume":"156","author":"Petejova","year":"2012","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0022","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/jac\/dkt261","article-title":"A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy","volume":"68","author":"Beumier","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0023","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1128\/AAC.00222-10","article-title":"Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury","volume":"54","author":"Roberts","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.03.001_bib0024","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/AAC.01708-10","article-title":"Vancomycin dosing in critically ill patients \u2013 robust methods for improved continuous infusion regimens","volume":"55","author":"Roberts","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918300724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918300724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T10:44:15Z","timestamp":1561718655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918300724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0924857918300724"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.03.001","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}